199 related articles for article (PubMed ID: 20726679)
1. Prescription drug costs and the generic dispensing ratio.
Liberman JN; Roebuck MC
J Manag Care Pharm; 2010 Sep; 16(7):502-6. PubMed ID: 20726679
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans.
Johnsrud M; Lawson KA; Shepherd MD
J Manag Care Pharm; 2007 Mar; 13(2):122-34. PubMed ID: 17330973
[TBL] [Abstract][Full Text] [Related]
3. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
Johnson JT; Neill KK; Davis DA
J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
[TBL] [Abstract][Full Text] [Related]
4. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?
Tungol A; Starner CI; Gunderson BW; Schafer JA; Qiu Y; Gleason PP
J Manag Care Pharm; 2012; 18(9):690-700. PubMed ID: 23206212
[TBL] [Abstract][Full Text] [Related]
5. Impact of pharmacy benefit design on prescription drug utilization: a fixed effects analysis of plan sponsor data.
Roebuck MC; Liberman JN
Health Serv Res; 2009 Jun; 44(3):988-1009. PubMed ID: 19187183
[TBL] [Abstract][Full Text] [Related]
6. Effects of a physician office generic drug sampling system on generic dispensing ratios and drug costs in a large managed care organization.
Scott AB; Culley EJ; O'Donnell J
J Manag Care Pharm; 2007 Jun; 13(5):412-9. PubMed ID: 17605512
[TBL] [Abstract][Full Text] [Related]
7. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
[TBL] [Abstract][Full Text] [Related]
8. Addition of generic medication vouchers to a pharmacist academic detailing program: effects on the generic dispensing ratio in a physician-hospital organization.
Bhargava V; Greg ME; Shields MC
J Manag Care Pharm; 2010; 16(6):384-92. PubMed ID: 20635829
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
Pauly NJ; Brown JD
J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
[TBL] [Abstract][Full Text] [Related]
10. Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions.
Khandelwal N; Duncan I; Rubinstein E; Ahmed T; Pegus C
J Manag Care Pharm; 2012 Apr; 18(3):247-55. PubMed ID: 22468733
[TBL] [Abstract][Full Text] [Related]
11. Impact of brand drug discount cards on private insurer, government and patient expenditures.
Law MR; Chan FKI; Harrison M; Worthington HC
CMAJ; 2019 Nov; 191(45):E1237-E1241. PubMed ID: 31712357
[TBL] [Abstract][Full Text] [Related]
12. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
Clark BE; Siracuse MV; Garis RI
Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
[TBL] [Abstract][Full Text] [Related]
13. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
Cecil WT; Barnes J; Shea T; Coulter SL
J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
[TBL] [Abstract][Full Text] [Related]
14. Discontinuation rates and health care costs in adult patients starting generic versus brand SSRI or SNRI antidepressants in commercial health plans.
Vlahiotis A; Devine ST; Eichholz J; Kautzner A
J Manag Care Pharm; 2011 Mar; 17(2):123-32. PubMed ID: 21348545
[TBL] [Abstract][Full Text] [Related]
15. Measuring economic impact of applying daily average consumption limits.
Flavin BM; Nishida LM; Karbowicz SH; Renner ME; Leonard RJ
J Manag Care Pharm; 2014 Feb; 20(2):159-64. PubMed ID: 24456317
[TBL] [Abstract][Full Text] [Related]
16. The relationship of antidepressant prescribing concentration to treatment duration and cost.
Hodgkin D; Merrick EL; Hiatt D
J Ment Health Policy Econ; 2012 Mar; 15(1):3-11. PubMed ID: 22611088
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Florida Medicaid's State-Mandated Formulary Provision on Prescription Drug Use and Health Plan Costs in a Medicaid Managed Care Plan.
Munshi KD; Mager D; Ward KM; Mischel B; Henderson RR
J Manag Care Spec Pharm; 2018 Feb; 24(2):124-131. PubMed ID: 29384030
[TBL] [Abstract][Full Text] [Related]
18. Utilization and drug cost outcomes of a step-therapy edit for generic antidepressants in an HMO in an integrated health system.
Dunn JD; Cannon E; Mitchell MP; Curtiss FR
J Manag Care Pharm; 2006 May; 12(4):294-302. PubMed ID: 16792435
[TBL] [Abstract][Full Text] [Related]
19. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.
Klepser DG; Huether JR; Handke LJ; Williams CE
J Manag Care Pharm; 2007; 13(9):765-77. PubMed ID: 18062728
[TBL] [Abstract][Full Text] [Related]
20. Generic script share and the price of brand-name drugs: the role of consumer choice.
Rizzo JA; Zeckhauser R
Int J Health Care Finance Econ; 2009 Sep; 9(3):291-316. PubMed ID: 19130220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
